MedTrace Logo

Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation

NCT00280839 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2012-04-13

No results posted yet for this study

Summary

The purpose of this research study is to determine if topiramate is safe and effective in the treatment of smoking cessation

Conditions

  • Smoking Cessation

Interventions

DRUG

Topiramate

DRUG

Placebo

Sponsors & Collaborators

  • Ortho-McNeil Neurologics, Inc.

    collaborator INDUSTRY

  • University of Cincinnati

    collaborator OTHER

  • Lindner Center of HOPE

    lead OTHER

Principal Investigators

  • Paul Keck, Jr., MD · University of Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00280839 on ClinicalTrials.gov